Concepts (245)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Migraine Disorders | 37 | 2023 | 1631 | 5.910 |
Why?
|
Stroke | 24 | 2023 | 9693 | 2.360 |
Why?
|
Brain Ischemia | 11 | 2022 | 3071 | 1.810 |
Why?
|
Cacao | 6 | 2024 | 98 | 1.760 |
Why?
|
Intracranial Hemorrhages | 5 | 2020 | 836 | 1.230 |
Why?
|
Activities of Daily Living | 8 | 2020 | 2385 | 1.130 |
Why?
|
Manipulation, Spinal | 3 | 2021 | 21 | 1.040 |
Why?
|
Migraine with Aura | 4 | 2021 | 203 | 1.030 |
Why?
|
Leukoencephalopathies | 2 | 2019 | 247 | 0.930 |
Why?
|
Restless Legs Syndrome | 2 | 2015 | 228 | 0.800 |
Why?
|
Recovery of Function | 5 | 2014 | 2925 | 0.770 |
Why?
|
Cognition Disorders | 7 | 2015 | 3962 | 0.770 |
Why?
|
Leukoaraiosis | 1 | 2022 | 115 | 0.770 |
Why?
|
Fatty Acids, Omega-3 | 2 | 2021 | 1367 | 0.760 |
Why?
|
Chiropractic | 1 | 2020 | 39 | 0.730 |
Why?
|
Migraine without Aura | 3 | 2021 | 82 | 0.720 |
Why?
|
Disabled Persons | 4 | 2015 | 1192 | 0.690 |
Why?
|
Ischemic Attack, Transient | 3 | 2014 | 895 | 0.670 |
Why?
|
Neurofilament Proteins | 1 | 2021 | 316 | 0.650 |
Why?
|
Headache | 3 | 2020 | 1224 | 0.630 |
Why?
|
Cardiovascular Diseases | 13 | 2024 | 15316 | 0.590 |
Why?
|
Dementia | 4 | 2016 | 2547 | 0.580 |
Why?
|
Retinol-Binding Proteins, Plasma | 1 | 2017 | 94 | 0.570 |
Why?
|
Headache Disorders | 2 | 2020 | 138 | 0.560 |
Why?
|
Alcohol Drinking | 3 | 2016 | 3962 | 0.560 |
Why?
|
Spouses | 2 | 2016 | 268 | 0.550 |
Why?
|
beta 2-Microglobulin | 1 | 2017 | 315 | 0.550 |
Why?
|
Vitamins | 9 | 2024 | 1611 | 0.550 |
Why?
|
Triglycerides | 3 | 2019 | 2434 | 0.500 |
Why?
|
Exercise | 3 | 2017 | 5689 | 0.470 |
Why?
|
Prospective Studies | 21 | 2023 | 53276 | 0.470 |
Why?
|
Risk Factors | 32 | 2024 | 72453 | 0.460 |
Why?
|
Women's Health | 6 | 2023 | 2038 | 0.450 |
Why?
|
Depression | 5 | 2018 | 7827 | 0.440 |
Why?
|
Motor Activity | 2 | 2015 | 2670 | 0.440 |
Why?
|
Vitamin D | 3 | 2022 | 3239 | 0.440 |
Why?
|
Aged | 40 | 2024 | 164472 | 0.420 |
Why?
|
Life Style | 3 | 2019 | 3823 | 0.410 |
Why?
|
Female | 62 | 2024 | 382617 | 0.400 |
Why?
|
Cardiology | 1 | 2023 | 1678 | 0.400 |
Why?
|
Cholesterol, LDL | 2 | 2019 | 2375 | 0.390 |
Why?
|
Arteritis | 2 | 2024 | 162 | 0.380 |
Why?
|
Hyperglycemia | 1 | 2020 | 1354 | 0.380 |
Why?
|
Middle Aged | 43 | 2024 | 214711 | 0.380 |
Why?
|
Smoking | 5 | 2020 | 8983 | 0.380 |
Why?
|
Humans | 86 | 2024 | 746897 | 0.380 |
Why?
|
Lipids | 3 | 2024 | 3290 | 0.370 |
Why?
|
Cohort Studies | 19 | 2023 | 40540 | 0.350 |
Why?
|
Food Supply | 1 | 2015 | 510 | 0.350 |
Why?
|
Randomized Controlled Trials as Topic | 12 | 2024 | 10096 | 0.350 |
Why?
|
Dietary Supplements | 10 | 2024 | 3324 | 0.340 |
Why?
|
Double-Blind Method | 8 | 2024 | 12231 | 0.340 |
Why?
|
Health Status | 2 | 2019 | 4022 | 0.330 |
Why?
|
Tai Ji | 2 | 2023 | 281 | 0.320 |
Why?
|
Logistic Models | 7 | 2017 | 13171 | 0.320 |
Why?
|
Nursing Homes | 1 | 2016 | 1049 | 0.320 |
Why?
|
Patient Admission | 1 | 2016 | 1359 | 0.310 |
Why?
|
Rehabilitation | 2 | 2009 | 129 | 0.310 |
Why?
|
Hyperlipidemias | 2 | 2020 | 776 | 0.300 |
Why?
|
Research Design | 3 | 2021 | 6066 | 0.290 |
Why?
|
Utilization Review | 1 | 2008 | 382 | 0.280 |
Why?
|
Cholesterol, HDL | 3 | 2020 | 1801 | 0.280 |
Why?
|
Cerebrovascular Disorders | 1 | 2013 | 1484 | 0.260 |
Why?
|
Pilot Projects | 4 | 2023 | 8378 | 0.260 |
Why?
|
Risk | 5 | 2019 | 9522 | 0.240 |
Why?
|
Myocardial Infarction | 4 | 2022 | 11663 | 0.240 |
Why?
|
Incidence | 7 | 2021 | 20822 | 0.240 |
Why?
|
Plant Extracts | 3 | 2023 | 489 | 0.240 |
Why?
|
Cognition | 5 | 2024 | 6786 | 0.240 |
Why?
|
Male | 39 | 2024 | 351556 | 0.230 |
Why?
|
Arthritis, Rheumatoid | 3 | 2024 | 3734 | 0.230 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2244 | 0.230 |
Why?
|
Antirheumatic Agents | 2 | 2024 | 1351 | 0.230 |
Why?
|
Aged, 80 and over | 12 | 2020 | 57627 | 0.230 |
Why?
|
Aspirin | 2 | 2013 | 3288 | 0.220 |
Why?
|
Odds Ratio | 7 | 2017 | 9600 | 0.220 |
Why?
|
Body Mass Index | 3 | 2017 | 12659 | 0.220 |
Why?
|
Follow-Up Studies | 10 | 2020 | 38812 | 0.210 |
Why?
|
Longitudinal Studies | 7 | 2017 | 14126 | 0.210 |
Why?
|
France | 2 | 2015 | 500 | 0.200 |
Why?
|
Manipulation, Chiropractic | 1 | 2021 | 22 | 0.190 |
Why?
|
Health Surveys | 3 | 2019 | 3961 | 0.190 |
Why?
|
Methotrexate | 2 | 2024 | 1719 | 0.180 |
Why?
|
Intermediate Filaments | 1 | 2021 | 168 | 0.180 |
Why?
|
Hydroxychloroquine | 1 | 2024 | 421 | 0.180 |
Why?
|
Probability | 2 | 2017 | 2470 | 0.180 |
Why?
|
Disability Evaluation | 3 | 2016 | 1810 | 0.180 |
Why?
|
Magnetic Resonance Imaging | 4 | 2022 | 35829 | 0.170 |
Why?
|
Nurses | 3 | 2017 | 2441 | 0.170 |
Why?
|
Hypertension | 2 | 2020 | 8368 | 0.160 |
Why?
|
Apolipoprotein A-I | 1 | 2020 | 296 | 0.160 |
Why?
|
Integrative Medicine | 1 | 2020 | 86 | 0.160 |
Why?
|
Hemostasis | 1 | 2021 | 447 | 0.160 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 2 | 2010 | 322 | 0.160 |
Why?
|
Arteries | 1 | 2023 | 1115 | 0.160 |
Why?
|
Memory Disorders | 2 | 2016 | 1175 | 0.150 |
Why?
|
Geriatric Assessment | 2 | 2016 | 1369 | 0.150 |
Why?
|
Marital Status | 2 | 2016 | 430 | 0.150 |
Why?
|
Education | 1 | 2020 | 530 | 0.140 |
Why?
|
Task Performance and Analysis | 1 | 2021 | 760 | 0.140 |
Why?
|
Case-Control Studies | 6 | 2021 | 21702 | 0.140 |
Why?
|
Diet | 1 | 2014 | 7888 | 0.140 |
Why?
|
Cross-Sectional Studies | 7 | 2023 | 25197 | 0.140 |
Why?
|
Neoplasms | 2 | 2022 | 21723 | 0.130 |
Why?
|
Genetic Predisposition to Disease | 7 | 2021 | 17452 | 0.130 |
Why?
|
Muscle Contraction | 1 | 2021 | 1203 | 0.130 |
Why?
|
Complementary Therapies | 1 | 2020 | 479 | 0.130 |
Why?
|
Polymorphism, Genetic | 3 | 2011 | 4276 | 0.130 |
Why?
|
Gait | 1 | 2021 | 799 | 0.130 |
Why?
|
Meta-Analysis as Topic | 1 | 2020 | 1358 | 0.130 |
Why?
|
Accidental Falls | 1 | 2023 | 1035 | 0.120 |
Why?
|
Genome-Wide Association Study | 4 | 2021 | 12216 | 0.120 |
Why?
|
Obesity | 2 | 2020 | 12724 | 0.120 |
Why?
|
Severity of Illness Index | 3 | 2019 | 15562 | 0.120 |
Why?
|
Widowhood | 1 | 2014 | 48 | 0.120 |
Why?
|
Drug Therapy, Combination | 1 | 2024 | 6465 | 0.120 |
Why?
|
Survivors | 2 | 2022 | 2303 | 0.110 |
Why?
|
Multivariate Analysis | 2 | 2017 | 12021 | 0.110 |
Why?
|
Brain Neoplasms | 1 | 2015 | 8852 | 0.110 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2017 | 485 | 0.110 |
Why?
|
Lower Extremity | 1 | 2021 | 1178 | 0.110 |
Why?
|
Aging | 1 | 2011 | 8491 | 0.100 |
Why?
|
Cholesterol | 2 | 2012 | 2881 | 0.100 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2020 | 15387 | 0.100 |
Why?
|
Mobility Limitation | 1 | 2016 | 403 | 0.100 |
Why?
|
Treatment Outcome | 7 | 2024 | 63767 | 0.100 |
Why?
|
Comorbidity | 2 | 2017 | 10378 | 0.100 |
Why?
|
Lymphotoxin-alpha | 1 | 2011 | 96 | 0.100 |
Why?
|
Chi-Square Distribution | 1 | 2017 | 3430 | 0.090 |
Why?
|
Brain | 3 | 2022 | 26606 | 0.090 |
Why?
|
Prognosis | 3 | 2017 | 29088 | 0.090 |
Why?
|
Mendelian Randomization Analysis | 3 | 2021 | 942 | 0.090 |
Why?
|
Diet Surveys | 1 | 2014 | 1150 | 0.090 |
Why?
|
Feasibility Studies | 1 | 2021 | 5096 | 0.090 |
Why?
|
Risk Assessment | 2 | 2023 | 23470 | 0.090 |
Why?
|
Psychological Tests | 1 | 2012 | 638 | 0.090 |
Why?
|
Bereavement | 1 | 2014 | 293 | 0.090 |
Why?
|
Neuropsychological Tests | 2 | 2014 | 6949 | 0.090 |
Why?
|
Adult | 11 | 2024 | 215291 | 0.080 |
Why?
|
Organ Size | 1 | 2014 | 2245 | 0.080 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2009 | 279 | 0.080 |
Why?
|
Educational Status | 1 | 2016 | 2486 | 0.080 |
Why?
|
Patient Satisfaction | 1 | 2021 | 3416 | 0.080 |
Why?
|
Sex Factors | 3 | 2017 | 10287 | 0.080 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2009 | 357 | 0.080 |
Why?
|
Sex Characteristics | 1 | 2018 | 2565 | 0.070 |
Why?
|
Linear Models | 1 | 2017 | 5832 | 0.070 |
Why?
|
Curriculum | 1 | 2020 | 3626 | 0.070 |
Why?
|
Residence Characteristics | 1 | 2016 | 2003 | 0.070 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2022 | 4343 | 0.070 |
Why?
|
Vitamin E | 1 | 2010 | 871 | 0.070 |
Why?
|
Estrogen Receptor alpha | 1 | 2010 | 572 | 0.070 |
Why?
|
Self Report | 1 | 2017 | 3593 | 0.070 |
Why?
|
Muscle, Skeletal | 1 | 2021 | 4865 | 0.070 |
Why?
|
Pain | 1 | 2021 | 4982 | 0.060 |
Why?
|
Receptors, Progesterone | 1 | 2010 | 1109 | 0.060 |
Why?
|
Blood Pressure | 1 | 2020 | 8405 | 0.060 |
Why?
|
Sulfasalazine | 1 | 2024 | 85 | 0.060 |
Why?
|
Memory | 1 | 2014 | 2170 | 0.060 |
Why?
|
Poverty | 1 | 2015 | 2616 | 0.060 |
Why?
|
United States | 6 | 2017 | 70460 | 0.060 |
Why?
|
Disease Progression | 1 | 2021 | 13326 | 0.060 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 15010 | 0.060 |
Why?
|
Inflammation Mediators | 1 | 2012 | 1858 | 0.060 |
Why?
|
Pandemics | 1 | 2023 | 8445 | 0.050 |
Why?
|
Socioeconomic Factors | 1 | 2017 | 7685 | 0.050 |
Why?
|
Minerals | 1 | 2024 | 279 | 0.050 |
Why?
|
Patients | 1 | 2009 | 898 | 0.050 |
Why?
|
Fibrinopeptide A | 1 | 2021 | 43 | 0.050 |
Why?
|
Factor XI | 1 | 2021 | 32 | 0.050 |
Why?
|
Prothrombin Time | 1 | 2021 | 117 | 0.050 |
Why?
|
Recurrence | 1 | 2013 | 8388 | 0.050 |
Why?
|
Factor VII | 1 | 2021 | 133 | 0.050 |
Why?
|
C-Reactive Protein | 1 | 2012 | 3752 | 0.050 |
Why?
|
Ovarian Neoplasms | 1 | 2017 | 4857 | 0.050 |
Why?
|
Prevalence | 2 | 2014 | 15308 | 0.050 |
Why?
|
Receptors, Adrenergic, alpha-2 | 1 | 2020 | 64 | 0.050 |
Why?
|
Partial Thromboplastin Time | 1 | 2021 | 205 | 0.040 |
Why?
|
Integrin beta Chains | 1 | 2020 | 115 | 0.040 |
Why?
|
Vasculitis | 1 | 2024 | 520 | 0.040 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2021 | 269 | 0.040 |
Why?
|
Attitude to Health | 1 | 2009 | 2028 | 0.040 |
Why?
|
Health Personnel | 2 | 2014 | 3230 | 0.040 |
Why?
|
Genotype | 4 | 2021 | 12790 | 0.040 |
Why?
|
International Normalized Ratio | 1 | 2021 | 364 | 0.040 |
Why?
|
Postural Balance | 1 | 2023 | 607 | 0.040 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2021 | 411 | 0.040 |
Why?
|
Alzheimer Disease | 1 | 2020 | 8309 | 0.040 |
Why?
|
Factor VIII | 1 | 2021 | 346 | 0.040 |
Why?
|
Young Adult | 2 | 2023 | 57221 | 0.040 |
Why?
|
Quality of Life | 2 | 2018 | 12980 | 0.040 |
Why?
|
Epilepsy | 1 | 2013 | 3277 | 0.040 |
Why?
|
Fibrinogen | 1 | 2021 | 866 | 0.040 |
Why?
|
von Willebrand Factor | 1 | 2021 | 651 | 0.040 |
Why?
|
Adolescent | 2 | 2023 | 86323 | 0.030 |
Why?
|
Lipoproteins | 1 | 2021 | 883 | 0.030 |
Why?
|
Qualitative Research | 2 | 2021 | 2843 | 0.030 |
Why?
|
Proportional Hazards Models | 3 | 2016 | 12281 | 0.030 |
Why?
|
Telomerase | 1 | 2020 | 720 | 0.030 |
Why?
|
Tissue Plasminogen Activator | 1 | 2021 | 1151 | 0.030 |
Why?
|
Executive Function | 1 | 2023 | 1354 | 0.030 |
Why?
|
Intelligence | 1 | 2020 | 912 | 0.030 |
Why?
|
Models, Cardiovascular | 1 | 2020 | 958 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2022 | 20775 | 0.030 |
Why?
|
Attitude of Health Personnel | 1 | 2008 | 3835 | 0.030 |
Why?
|
Hydrocortisone | 1 | 2022 | 1792 | 0.030 |
Why?
|
Gene Frequency | 2 | 2011 | 3534 | 0.030 |
Why?
|
Mice | 1 | 2020 | 80291 | 0.030 |
Why?
|
Immunologic Factors | 1 | 2022 | 1565 | 0.030 |
Why?
|
Diabetes Complications | 1 | 2020 | 1319 | 0.030 |
Why?
|
Independent Living | 1 | 2016 | 559 | 0.020 |
Why?
|
Pain Measurement | 1 | 2021 | 3442 | 0.020 |
Why?
|
Receptors, FSH | 1 | 2010 | 29 | 0.020 |
Why?
|
Health Promotion | 1 | 2022 | 2190 | 0.020 |
Why?
|
Aromatase | 1 | 2010 | 146 | 0.020 |
Why?
|
Estrogen Receptor beta | 1 | 2010 | 168 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2016 | 2608 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2021 | 3647 | 0.020 |
Why?
|
Animals | 1 | 2020 | 166593 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2012 | 11966 | 0.020 |
Why?
|
Age Distribution | 1 | 2014 | 2839 | 0.020 |
Why?
|
Age Factors | 2 | 2018 | 18160 | 0.020 |
Why?
|
Contraceptives, Oral | 1 | 2009 | 550 | 0.020 |
Why?
|
Brain Chemistry | 1 | 2010 | 969 | 0.020 |
Why?
|
Sex Distribution | 1 | 2011 | 2257 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2011 | 2920 | 0.020 |
Why?
|
Proteins | 1 | 2020 | 6010 | 0.020 |
Why?
|
Phenotype | 1 | 2021 | 16273 | 0.010 |
Why?
|
Receptors, Androgen | 1 | 2010 | 1067 | 0.010 |
Why?
|
Europe | 1 | 2010 | 3355 | 0.010 |
Why?
|
Genetic Markers | 1 | 2009 | 2595 | 0.010 |
Why?
|
Models, Genetic | 1 | 2011 | 3425 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2009 | 4125 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2010 | 2679 | 0.010 |
Why?
|
Alleles | 1 | 2011 | 6841 | 0.010 |
Why?
|
Mental Health | 1 | 2014 | 3087 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2010 | 2886 | 0.010 |
Why?
|
Patient-Centered Care | 1 | 2009 | 1400 | 0.010 |
Why?
|
Acute Disease | 1 | 2009 | 7126 | 0.010 |
Why?
|
Coronary Disease | 1 | 2011 | 5929 | 0.010 |
Why?
|
Genetic Testing | 1 | 2009 | 3479 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2010 | 5748 | 0.010 |
Why?
|
Decision Making | 1 | 2009 | 3856 | 0.010 |
Why?
|
Child | 1 | 2022 | 78517 | 0.010 |
Why?
|
Time Factors | 1 | 2014 | 39639 | 0.010 |
Why?
|
Concepts
(245)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(53)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_